|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Gene regulation
|
 |
|
Title:
|
 |
The phd finger of ing4 in complex with an h3k4me3 histone peptide
|
|
Structure:
|
 |
Inhibitor of growth protein 4. Chain: a, c. Fragment: phd domain, residues 194-246. Synonym: p29ing4. Engineered: yes. H3k4me3 peptide. Chain: b, d. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ing4. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Other_details: the peptide h3k4me3 is naturally found in homo sapiens (human).
|
|
Resolution:
|
 |
|
1.80Å
|
R-factor:
|
0.199
|
R-free:
|
0.211
|
|
|
Authors:
|
 |
K.S.Champagne,K.Johnson,T.G.Kutateladze
|
Key ref:
|
 |
T.Hung
et al.
(2009).
ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation.
Mol Cell,
33,
248-256.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
25-Apr-07
|
Release date:
|
15-Apr-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q9UNL4
(ING4_HUMAN) -
Inhibitor of growth protein 4
|
|
|
|
Seq: Struc:
|
 |
 |
 |
249 a.a.
51 a.a.
|
|
|
|
|
|
|
 |
 |
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
protein binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Mol Cell
33:248-256
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation.
|
|
T.Hung,
O.Binda,
K.S.Champagne,
A.J.Kuo,
K.Johnson,
H.Y.Chang,
M.D.Simon,
T.G.Kutateladze,
O.Gozani.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Aberrations in chromatin dynamics play a fundamental role in tumorigenesis, yet
relatively little is known of the molecular mechanisms linking histone lysine
methylation to neoplastic disease. ING4 (Inhibitor of Growth 4) is a native
subunit of an HBO1 histone acetyltransferase (HAT) complex and a tumor
suppressor protein. Here we show a critical role for specific recognition of
histone H3 trimethylated at lysine 4 (H3K4me3) by the ING4 PHD finger in
mediating ING4 gene expression and tumor suppressor functions. The interaction
between ING4 and H3K4me3 augments HBO1 acetylation activity on H3 tails and
drives H3 acetylation at ING4 target promoters. Further, ING4 facilitates
apoptosis in response to genotoxic stress and inhibits anchorage-independent
cell growth, and these functions depend on ING4 interactions with H3K4me3.
Together, our results demonstrate a mechanism for brokering crosstalk between
H3K4 methylation and H3 acetylation and reveal a molecular link between
chromatin modulation and tumor suppressor mechanisms.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. The ING4 PHD Finger Binds Specifically to H3K4me3
(A) ING4[PHD] preferentially binds H3K4me3 peptides.
Microarrays spotted with the indicated histone peptides (as in
Matthews et al., 2007) were probed with glutathione
S-transferase (GST) fused to ING4[195–241] (ING4[PHD]). Red
spots indicate positive binding. H3, histone H3; H4, histone H4;
me, methylation; ac, acetylation; ph, phosphorylation; s,
symmetric; a, asymmetric. (B) Western analysis of histone
peptide pulldowns with GST-ING4[PHD] and the indicated
biotinylated peptides. (C) Full-length ING4, but not
ING4[ΔPHD], recognizes H3K4me3. Histone peptide pulldowns are
as in (B) with the indicated protein. (D) 1.8 Å
crystal structure of the ING4[PHD]-H3K4me3 complex. The PHD
finger is shown as a solid surface with the binding site
residues colored and labeled. H3K4 and H3R2 binding grooves are
in brown and yellow. The histone peptide is shown as
ball-and-stick model with C, O, and N atoms colored green, red,
and blue, respectively. (E) Superimposition of the backbone
structures of the ING4 (brown) and ING2 (gray) PHD fingers bound
to H3K4me3 (green and gray stick models, respectively). (F)
ING4[PHD] binds with highest affinity to H3K4me3. Tryptophan
fluorescence was used to determine disassociation constants
(Kds) for the interaction between the ING4[PHD] and the
indicated peptides. ^*H3K4me3 Kd was previously determined (Pena
et al., 2006).
|
 |
Figure 2.
Figure 2. ING4[PHD] Binding to H3K4me3 Promotes HBO1
Acetylation of Histone H3 (A) Identification of residues in
the ING4 PHD finger critical for H3K4me3 binding. Western blot
of histone peptide pull-down assays with the indicated
GST-fusion proteins and biotinylated peptides. (B)
ING4[PHD] binding to polynucleosomes is abrogated by
substitution of critical residues in the H3K4me3-binding
surface. The indicated recombinant proteins were incubated with
purified polynucleosomes and binding was determined by western
analysis with antibodies against the four core histones and
H3K4me3 and H3K9me3 antibodies. (C) The ING4 interaction
with H3K4me3 occurs at chromatin in vivo and requires an intact
PHD finger. Western analysis of wild-type or mutant Flag-ING4
protein-protein ChIPs. ING2 is used as a positive control. Input
represents 5% of total. (D) Western analysis of
affinity-purified Flag-ING4 and Flag-ING4[D213A] complexes with
the indicated antibodies. Control, empty vector IP. (E and
F) Histone acetylation by HBO1 in wild-type, but not mutant,
ING4 complexes is increased by binding to H3K4me. Autoradiograms
of in vitro HAT reactions by ING4 complexes with the indicated
MLA nucleosomes. Western analysis of histones is shown as a
loading control. (G) Quantitation of HAT activity of ING4
and ING4[D213A] complexes on the indicated histone peptides from
three independent experiments, except for asterisks (^*), which
indicate two independent experiments. Error bars indicate the
SEM.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2009,
33,
248-256)
copyright 2009.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.H.Aguissa-Touré,
R.P.Wong,
and
G.Li
(2011).
The ING family tumor suppressors: from structure to function.
|
| |
Cell Mol Life Sci, 68,
45-54.
|
 |
|
|
|
|
 |
C.D.Allis,
and
T.W.Muir
(2011).
Spreading chromatin into chemical biology.
|
| |
Chembiochem, 12,
264-279.
|
 |
|
|
|
|
 |
K.M.Tchou-Wong,
K.Kiok,
Z.Tang,
T.Kluz,
A.Arita,
P.R.Smith,
S.Brown,
and
M.Costa
(2011).
Effects of nickel treatment on H3K4 trimethylation and gene expression.
|
| |
PLoS One, 6,
e17728.
|
 |
|
|
|
|
 |
M.Abad,
A.Moreno,
A.Palacios,
M.Narita,
F.Blanco,
G.Moreno-Bueno,
M.Narita,
and
I.Palmero
(2011).
The tumor suppressor ING1 contributes to epigenetic control of cellular senescence.
|
| |
Aging Cell, 10,
158-171.
|
 |
|
|
|
|
 |
N.T.Crump,
C.A.Hazzalin,
E.M.Bowers,
R.M.Alani,
P.A.Cole,
and
L.C.Mahadevan
(2011).
Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP.
|
| |
Proc Natl Acad Sci U S A, 108,
7814-7819.
|
 |
|
|
|
|
 |
O.Binda,
M.Boyce,
J.S.Rush,
K.K.Palaniappan,
C.R.Bertozzi,
and
O.Gozani
(2011).
A chemical method for labeling lysine methyltransferase substrates.
|
| |
Chembiochem, 12,
330-334.
|
 |
|
|
|
|
 |
P.Voigt,
and
D.Reinberg
(2011).
Histone tails: ideal motifs for probing epigenetics through chemical biology approaches.
|
| |
Chembiochem, 12,
236-252.
|
 |
|
|
|
|
 |
S.M.Fuchs,
K.Krajewski,
R.W.Baker,
V.L.Miller,
and
B.D.Strahl
(2011).
Influence of combinatorial histone modifications on antibody and effector protein recognition.
|
| |
Curr Biol, 21,
53-58.
|
 |
|
|
|
|
 |
X.Li,
K.Kikuchi,
and
Y.Takano
(2011).
ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma.
|
| |
J Oncol, 2011,
963614.
|
 |
|
|
|
|
 |
A.Moreno,
A.Palacios,
J.L.Orgaz,
B.Jimenez,
F.J.Blanco,
and
I.Palmero
(2010).
Functional impact of cancer-associated mutations in the tumor suppressor protein ING4.
|
| |
Carcinogenesis, 31,
1932-1938.
|
 |
|
|
|
|
 |
B.Piche,
and
G.Li
(2010).
Inhibitor of growth tumor suppressors in cancer progression.
|
| |
Cell Mol Life Sci, 67,
1987-1999.
|
 |
|
|
|
|
 |
C.Chatterjee,
and
T.W.Muir
(2010).
Chemical approaches for studying histone modifications.
|
| |
J Biol Chem, 285,
11045-11050.
|
 |
|
|
|
|
 |
D.Faucher,
and
R.J.Wellinger
(2010).
Methylated H3K4, a transcription-associated histone modification, is involved in the DNA damage response pathway.
|
| |
PLoS Genet, 6,
0.
|
 |
|
|
|
|
 |
K.L.Yap,
and
M.M.Zhou
(2010).
Keeping it in the family: diverse histone recognition by conserved structural folds.
|
| |
Crit Rev Biochem Mol Biol, 45,
488-505.
|
 |
|
|
|
|
 |
M.D.Plazas-Mayorca,
J.S.Bloom,
U.Zeissler,
G.Leroy,
N.L.Young,
P.A.DiMaggio,
L.Krugylak,
R.Schneider,
and
B.A.Garcia
(2010).
Quantitative proteomics reveals direct and indirect alterations in the histone code following methyltransferase knockdown.
|
| |
Mol Biosyst, 6,
1719-1729.
|
 |
|
|
|
|
 |
N.L.Young,
P.A.Dimaggio,
and
B.A.Garcia
(2010).
The significance, development and progress of high-throughput combinatorial histone code analysis.
|
| |
Cell Mol Life Sci, 67,
3983-4000.
|
 |
|
|
|
|
 |
P.Chi,
C.D.Allis,
and
G.G.Wang
(2010).
Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.
|
| |
Nat Rev Cancer, 10,
457-469.
|
 |
|
|
|
|
 |
R.Collins,
and
X.Cheng
(2010).
A case study in cross-talk: the histone lysine methyltransferases G9a and GLP.
|
| |
Nucleic Acids Res, 38,
3503-3511.
|
 |
|
|
|
|
 |
W.W.Tsai,
Z.Wang,
T.T.Yiu,
K.C.Akdemir,
W.Xia,
S.Winter,
C.Y.Tsai,
X.Shi,
D.Schwarzer,
W.Plunkett,
B.Aronow,
O.Gozani,
W.Fischle,
M.C.Hung,
D.J.Patel,
and
M.C.Barton
(2010).
TRIM24 links a non-canonical histone signature to breast cancer.
|
| |
Nature, 468,
927-932.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.A.Musselman,
and
T.G.Kutateladze
(2009).
PHD fingers: epigenetic effectors and potential drug targets.
|
| |
Mol Interv, 9,
314-323.
|
 |
|
|
|
|
 |
D.J.Bua,
A.J.Kuo,
P.Cheung,
C.L.Liu,
V.Migliori,
A.Espejo,
F.Casadio,
C.Bassi,
B.Amati,
M.T.Bedford,
E.Guccione,
and
O.Gozani
(2009).
Epigenome microarray platform for proteome-wide dissection of chromatin-signaling networks.
|
| |
PLoS One, 4,
e6789.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
| |